Altimmune (ALT) Interest & Investment Income (2010 - 2026)

Altimmune (ALT) has 15 years of Interest & Investment Income data on file, last reported at $2.9 million in Q1 2026.

• Interest & Investment Income for Q1 2026 came in at $2.9 million, up 87.77% year-over-year; the trailing twelve-month figure through Mar 2026 was $8.9 million (up 23.47% YoY), and the FY2025 annual result was $7.5 million, down 6.6% from the prior year.
• Interest & Investment Income advanced to $2.9 million in Q1 2026 per ALT's latest filing, from $2.4 million in the prior quarter.
• Over five years, Interest & Investment Income peaked at $2.9 million in Q1 2026 and troughed at $21000.0 in Q1 2022.
• A 5-year average of $1.7 million and a median of $1.8 million in 2023 frame the typical range for Interest & Investment Income.
• On a YoY basis, Interest & Investment Income climbed as much as 8000.0% in 2022 and fell as far as 50.0% in 2022.
• A 5-year view of Interest & Investment Income shows it stood at $1.5 million in 2022, then jumped by 33.79% to $2.0 million in 2023, then retreated by 20.11% to $1.6 million in 2024, then soared by 55.39% to $2.4 million in 2025, then grew by 18.99% to $2.9 million in 2026.
• Business Quant data shows ALT's Interest & Investment Income at $2.9 million in Q1 2026, $2.4 million in Q4 2025, and $2.4 million in Q3 2025.